High Blood Sugar Rewrites Pancreatic Cell Chemistry, Driving Stress Granule Buildup in Diabetes

Diabetes has long been understood as a disease of failing glucose regulation, but its quieter effects on the pancreas are only now coming into focus. A new study published in the Journal of Translational Medicine by researchers at Harbin Medical University reveals a surprising epigenetic mechanism by which chronic high blood sugar pushes one of the pancreas’s most overlooked cell types into a state of deep cellular stress. The team found that in pancreatic acinar cells, the workhorse cells that produce digestive enzymes, diabetes triggers a rise in a specific histone modification called H3K4me1, and that this chemical change on the DNA packaging machinery directly drives the formation of stress granules, dense cytoplasmic assemblies that cells build when protein synthesis goes haywire.

Stress granules are membraneless structures that suddenly appear inside cells when they face hostile conditions such as heat shock, oxidative damage, or nutrient deprivation. When translation of messenger RNA stalls, the stalled mRNA molecules, together with RNA-binding proteins like G3BP1 and TIA1, condense into these granules, effectively putting nonessential protein production on hold until conditions improve. In the short term, this is a survival strategy. But when stress granules persist or accumulate abnormally, they have been implicated in neurodegenerative disease and chronic inflammatory damage. Whether they play a role in diabetic injury of the pancreas had not been systematically explored until now.

The research team, led by corresponding author Dongbo Xue, began by mining single-cell RNA sequencing data from human pancreatic tissue affected by diabetes mellitus. This technology allows scientists to profile gene expression in thousands of individual cells at once, revealing how each cell population changes under disease conditions. Their analysis showed that under diabetic conditions, the proportion of acinar cells in the pancreatic tissue decreased, a sign that these cells are being lost or damaged. At the same time, the fraction of acinar cells that scored positive for stress granule related gene signatures increased, indicating that the surviving cells were under heightened stress.

To understand what was happening at the chromatin level, the investigators integrated chromatin immunoprecipitation sequencing data for H3K4me1, a histone mark in which a methyl group is added to the fourth lysine residue of histone H3 in a monomethylated form. H3K4me1 is classically associated with poised or active enhancer regions of the genome, and it can elevate transcription of nearby genes. The team found that the level of this modification was elevated in diabetes, and that the pattern of H3K4me1 enrichment corresponded to the changes in stress granule related gene expression seen in the acinar cell subtypes.

The critical question was whether this correlation reflected a genuine causal mechanism. To test it, the researchers turned to in vitro experiments using acinar cells exposed to a high glucose environment, mimicking the hyperglycemic conditions of diabetes. Western blotting, a technique that detects specific proteins by their size and antibody binding, showed that high glucose promoted the phosphorylation of eIF2α, a translation initiation factor whose phosphorylation is a classic trigger of the integrated stress response. When eIF2α is phosphorylated, protein synthesis is throttled back, and the stalled translation complexes become the raw material for stress granule assembly.

Consistent with this, the high glucose treatment increased the expression of G3BP1 and TIA1, two core scaffolding proteins of stress granules, and immunofluorescence imaging confirmed enhanced aggregation of stress granules within the treated cells. Immunofluorescence uses fluorescently labeled antibodies to light up specific molecules inside cells, allowing researchers to see directly where and how abundantly the granules form. The visual evidence matched the biochemical data: cells bathed in high glucose were visibly studded with stress granules compared with their normally cultured counterparts.

The epigenetic link was then tested directly. When the researchers inhibited H3K4me1, the expression of G3BP1 and TIA1 fell, and stress granule formation decreased accordingly. This result, confirmed by chromatin immunoprecipitation followed by quantitative PCR, a method that measures how much of a specific histone mark sits on particular gene promoters, establishes H3K4me1 as an upstream driver rather than a mere bystander. In other words, the hyperglycemic environment appears to rewire the epigenetic landscape of acinar cells, and that rewiring licenses the assembly of stress granules by boosting the production of the proteins that build them.

The findings carry several important implications. First, they identify pancreatic acinar cells as active participants in diabetic pathology, not just passive bystanders to the better known destruction of insulin producing beta cells. Acinar cells are the most abundant cell type in the pancreas and are responsible for secreting the enzymes that digest food in the small intestine. Their loss or dysfunction in diabetes could contribute to the exocrine pancreatic complications, including digestive problems and pancreatitis like inflammation, that are increasingly recognized in diabetic patients. Second, the study connects two fields that rarely intersect: chromatin biology and RNA stress physiology, suggesting that epigenetic marks may serve as master switches controlling how cells handle stress at the level of protein synthesis.

There is also a therapeutic dimension. If elevated H3K4me1 is what drives excessive stress granule formation in acinar cells, then pharmacological tools that modulate the enzymes responsible for writing or erasing this histone mark could, in principle, blunt the stress response and protect the pancreas from diabetic damage. The authors caution that their work is at an early stage, relying on human single cell data analysis and cell culture experiments rather than direct intervention in patients, and the study was published as an early version subject to further editorial refinement. Animal experiments in the study were conducted under approval from the Ethics Committee of the First Affiliated Hospital of Harbin Medical University and in compliance with ARRIVE 2.0 reporting guidelines, and the work was funded by the National Natural Science Foundation of China.

For the broader research community, the study opens a rich vein of follow up questions. Which specific genes are regulated by the elevated H3K4me1 in acinar cells, and are the same mechanisms at work in other tissues damaged by diabetes, such as the kidney, retina, and peripheral nerves? Do stress granules in acinar cells eventually dissolve and restore normal translation, or do they persist and seed pathological protein aggregation over years of hyperglycemia? And could stress granule signatures detected in pancreatic tissue or circulating biomarkers serve as early warning signs of acinar cell injury before overt disease appears? As the prevalence of diabetes continues to climb worldwide, understanding how high glucose rewrites the chemical instructions inside our cells, one methyl group at a time, may prove essential to protecting organs far beyond the insulin producing beta cells that have long dominated the conversation.

Subject of Research: Epigenetic regulation of stress granule formation in pancreatic acinar cells under diabetic hyperglycemia

Article Title: Elevated H3K4me1 in pancreatic acinar cells mediates stress granule formation in response to hyperglycemia in diabetes

Article References: He, Y., Li, L., Du, Z., Zheng, Y., Meng, Z., Liu, X., Xie, Z., Wang, H., Hao, C., & Xue, D. (2026). Elevated H3K4me1 in pancreatic acinar cells mediates stress granule formation in response to hyperglycemia in diabetes. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-08888-3

Image Credits: AI Generated

DOI: 10.1186/s12967-026-08888-3

Keywords: diabetes mellitus, pancreatic acinar cells, stress granules, H3K4me1, histone modification, epigenetics, hyperglycemia, G3BP1, TIA1, eIF2α phosphorylation, single-cell RNA sequencing, ChIP-seq